TRACT-RCT: Trans-diagnostic Group CBT vs. Standard Group CBT for Depression, Social Anxiety and Agoraphobia/Panic Disorder

Sponsor
Psychiatric Research Unit, Region Zealand, Denmark (Other)
Overall Status
Completed
CT.gov ID
NCT02954731
Collaborator
Aarhus University Hospital (Other), Mental Health Centre Copenhagen (Other), University of Copenhagen (Other)
292
4
2
36.3
73
2

Study Details

Study Description

Brief Summary

Transdiagnostic Cognitive Behavior Therapy (CBT) delivered in the individual format, have been proven just as effective as traditional diagnosis specific CBT manuals. The investigators have translated and modified the "The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders" (UP-CBT) to make it applicable as group therapy in Danish Mental Health Service and a naturalistic trial of this manual has shown promising results. As the use of one manual instead of several diagnosis specific manuals in regional clinics could simplify logistics and reduce waiting time, the investigators want to compare group UP-CBT with diagnosis specific group CBT.

Method: A partial blinded, pragmatic, non-inferiority, multicentre randomized clinical trial (RCT). UP-CBT is compared to treatment-as-usual CT. 124 patients are included in each intervention arm, recruited from three Danish regional Mental Health Service Clinics. 31st July 2018 suppl: Inclusion number expanded to 170 in each arm due to unexpected large drop-out.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: UP-CBT
  • Behavioral: Standard-CBT
N/A

Detailed Description

Background: Transdiagnostic Cognitive Behavior Therapy (TCBT) Manuals delivered in individual format, have been reported to be just as effective as traditional diagnosis specific CBT manuals. The investigators have translated and modified the "The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders" (UP-CBT) developed by Barlow and colleagues for use in Mental Health Service (MHS), and shown effects comparable to traditional CBT in a naturalistic trial. As the use of one manual instead of several diagnosis-specific manuals could simplify logistics, reduce waiting time, and increase therapist expertise compared to diagnosis specific CBT, the study aim to test the relative efficacy of group UP-CBT and diagnosis specific group CBT.

Methods/design: It is a partially blinded, pragmatic, non-inferiority, parallel, multi-center randomized controlled trial (RCT) of UP-CBT vs diagnosis specific CBT for depression, social anxiety disorder and agoraphobia/panic disorder. In both arms, the intervention consists of weekly group session for 14 weeks. In total, 248 patients are recruited from three regional

MHS centers across the country and included in two intervention arms.31st July 2018 suppl:

Inclusion number expanded to 340 due to unexpected large drop-out.

Outcomes are measured at end of therapy and at 6 months follow-up. Weekly patient-rated outcomes and group evaluations are collected for every session. Outcome assessors, blind to delivered intervention, will perform the observer-based symptom ratings, and fidelity assessors will monitor manual adherence.

Discussion: The current study will be the first RCT investigating the dissemination of the UP in a MHS setting and UP delivered in groups and including patients with depression. Hence the results are expected to add substantially to the evidence base for rational group psychotherapy in MHS. The planned moderator and mediator analyses could spur new hypotheses about mechanisms of change in psychotherapy and the association between patient characteristics and treatment effect.

Study Design

Study Type:
Interventional
Actual Enrollment :
292 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Trans-diagnostic Group CBT vs. Standard Group CBT for Depression, Social Anxiety and Agoraphobia/Panic Disorder: A Pragmatic, Multicenter Non-inferiority Randomized Controlled Trial
Study Start Date :
Dec 1, 2016
Actual Primary Completion Date :
Apr 11, 2019
Actual Study Completion Date :
Dec 11, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: UP-CBT

The "Unified Protocol for Transdiagnostic Treatment of Emotional Disorders" (UP) is one of the most widely studied transdiagnostic manuals. Here, the investigators apply a group manual that has been modified from the published UP for individual therapy based on recommendations on group delivery from the UP Institute (personal communications) and integrations modifications necessary for the delivery in the Mental Health Service. Group UP-CBT, consist of 8 treatment modules delivered in 14 group sessions given weekly in 2 hour sessions.

Behavioral: UP-CBT
Psychotherapy in groups based on the "Unified Protocol" a third generation CBT-type psychotherapy

Active Comparator: Standard-CBT

Group CBT following Danish versions of diagnosis specific manuals (Social Anxiety Disorder (SAD) Group; Depression (DEP) Group; Agoraphobia/Panic Disorder (Ag/PD) (standard-CBT). The original elements of psychoeducation, cognitive restructuring, and exposure/activity scheduling are present in the applied manuals. Standard-CBT, consist of 8 treatment modules delivered in 14 group sessions given weekly in 2 hour sessions.

Behavioral: Standard-CBT
Psychotherapy in groups based on diagnosis specific, manualized, cognitive behavior therapy

Outcome Measures

Primary Outcome Measures

  1. WHO Well-Being Index (WHO-5) [Week 19 after allocation]

    Self-rating questionnaire, 5 items on positive quality of life, web-based

Secondary Outcome Measures

  1. Hopkins Symptom Check List (SCL-25) [Week 19 after allocation]

    Validated questionnaire - web-based

  2. Work and Social Adjustment Scale (WSAS) [Week 19 after allocation]

    Validated questionnaire - web-based

  3. Hamilton Depression Rating Scale (HDRS) [Week 19 after allocation]

    6-item HDRS based on telephone interview

  4. Hamilton Anxiety Rating Scale (HARS) [Week 19 after allocation]

    6-item HARS based on telephone interview

Other Outcome Measures

  1. Overall Anxiety Severity and Impairment Scale (OASIS) [Weekly, weeks 4-19 after allocation, before session]

    Validated questionnaire

  2. Overall Depression Severity and Impairment Scale (ODSIS) [Weekly, weeks 4-19 after allocation, before session]

    Validated questionnaire

  3. WHO Well-Being Index (WHO-5) [Weekly, weeks 4-19 after allocation, before session]

    Validated questionnaire

  4. Positive Affect and Negative Affect Schedule (PANAS) [Week 19 after allocation]

    Validated questionnaire - web-based

  5. Positive Affect and Negative Affect Schedule (PANAS) [Week 42-43 after allocation]

    Validated questionnaire - web-based

  6. Hopkins Symptom Check List (SCL-25) [Week 42-43 after allocation]

    Validated questionnaire - web-based

  7. Emotion Regulation Questionnaire (ERQ) [Week 19 after allocation]

    Validated questionnaire - web-based

  8. Emotion Regulation Questionnaire (ERQ) [Week 42-43 after allocation]

    Validated questionnaire - web-based

  9. WHO Well-Being Index (WHO-5) [Week 42-43 after allocation]

    Self-rating questionnaire, 5 items on positive quality of life, web-based

  10. Emotion Regulation Strategies Questionnaire (ERSQ) [Week 19 after allocation]

    Validated questionnaire - web-based

  11. Emotion Regulation Strategies Questionnaire (ERSQ) [Week 42-43 after allocation]

    Validated questionnaire - web-based

  12. Perseverative Thinking Questionnaire (PTQ) [Week 19 after allocation]

    Validated questionnaire - web-based

  13. Perseverative Thinking Questionnaire (PTQ) [Week 42-43 after allocation]

    Validated questionnaires - web-based

  14. Becks Depression inventory (BDI-II) [Week 19 after allocation]

    Validated questionnaire - web-based

  15. Becks Depression inventory (BDI-II) [Week 42-43 after allocation]

    Validated questionnaire - web-based

  16. Work and Social Adjustment Scale (WSAS) [Week 42-43 after allocation]

    Validated questionnaire - web-based

  17. Personality Inventory for DSM-5 - Short Form (PID-5 SF) Negative Affectivity and Detachment domain scores [Week 19 after allocation]

    Validated questionnaire - web-based

  18. Personality Inventory for DSM-5 - Short Form (PID-5 SF) Negative Affectivity and Detachment domain scores [Week 42-43 after allocation]

    Validated questionnaire - web-based

  19. Liebowitch Social Anxiety Scale (LSAS) [Week 19 after allocation]

    Validated questionnaire - web-based

  20. Liebowitch Social Anxiety Scale (LSAS) [Week 42-43 after allocation]

    Validated questionnaire - web-based

  21. Panic Disorder Severity Scale (PDSS) [Week19 after allocation]

    Validated questionnaire - web-based

  22. Panic Disorder Severity Scale (PDSS) [Week 42-43 after allocation]

    Validated questionnaire - web-based

  23. Mobility Inventory for Agoraphobia (MIA) [Week 19 after allocation]

    Validated questionnaire - web-based

  24. Mobility Inventory for Agoraphobia (MIA) [Week 42-43 after allocation]

    Validated questionnaire - web-based

  25. Hamilton Depression Rating Scale [Week 42-43 after allocation]

    6-item HDRS based on telephone interview

  26. Hamilton Anxiety Rating Scale [Week 42-43 after allocation]

    6-item HARS based on telephone interview

  27. Client Satisfaction Questionnaire [Week 43]

    8-item validated questionnaire, web-based

  28. Patient Evaluation of Group Therapy [Week 19]

    Purpose-made questionnaire

  29. Group Questionnaire - brief [Weekly, weeks 4-19 after allocation, after session]

    8 items from validated questionnaire about group atmosphere

  30. Therapist Ratings of session methods and atmosphere [Weekly, weeks 4-19 after allocation, after session]

    Purpose-made questionnaire

  31. Homework and Event Tracker [Weekly, weeks 4-19 after allocation, before session]

    Purpose-made question for patients about homework and events previous week

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 64 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Referred to Danish Mental Health Service

  1. a principal DSM-5 diagnosis of Unipolar Depression (single episode or recurrent)(app. 50%), Social Anxiety Disorder (app. 25%), and Agoraphobia/Panic Disorder (app 25%)

  2. the patient is currently not using any antidepressants or use accepted antidepressants (according to predefined list), which have been unchanged for at least 4 weeks before inclusion and no change in antidepressants is anticipated,

  3. sufficient knowledge of the Danish language.

Exclusion Criteria:
  1. risk of suicide is high according to clinicians or assessment researchers

  2. alcohol or drug dependence,

  3. cluster A or B (DSM-5) personality disorder diagnosed by intake clinicians or assessment researcher,

  4. co-morbidity of pervasive developmental disorder, psychotic disorders, eating disorders, bipolar disorder, or severe physical illness,

  5. psychopharmacological treatment other than those predefined as acceptable,

  6. patient does not accept to stop the use of anxiolytics within the first four weeks of intervention.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Psychotherapeutic Unit, Mental Health Centre Copenhagen Copenhagen Capital Region Denmark 2200
2 Outpatient Clinic for Anxiety and Personality Disorders Risskov Central Region Denmark 8240
3 Outpatient Clinic for Mania and Depression Risskov Central Region Denmark 8240
4 Psychiatric Outpatient Clinic Slagelse Region Zealand Denmark 4200

Sponsors and Collaborators

  • Psychiatric Research Unit, Region Zealand, Denmark
  • Aarhus University Hospital
  • Mental Health Centre Copenhagen
  • University of Copenhagen

Investigators

  • Principal Investigator: Sidse MH Arnfred, MD,PhD,DMSc, Universityhospital Copenhagen, Psychiatry West, Mental Health Services Region Zealand

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
Sidse Arnfred, Associate Professor, Consultant, Psychiatric Research Unit, Region Zealand, Denmark
ClinicalTrials.gov Identifier:
NCT02954731
Other Study ID Numbers:
  • SA005
First Posted:
Nov 3, 2016
Last Update Posted:
Sep 16, 2020
Last Verified:
Sep 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Sidse Arnfred, Associate Professor, Consultant, Psychiatric Research Unit, Region Zealand, Denmark
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 16, 2020